title: Lorcaserin approval in the United States: paving the way?
authors.forename: Sue D
authors.initials: SD
authors.lastname: Pedersen
authors.forename: Arne
authors.initials: A
authors.lastname: Astrup
mesh_terms: D001067:Appetite Depressants / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D058826:Serotonin 5-HT2 Receptor Agonists / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D015431:Weight Loss
chemical_list: D001067:Appetite Depressants; D001552:Benzazepines; D058826:Serotonin 5-HT2 Receptor Agonists; C506658:lorcaserin